Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
- Conditions
- Unstable Angina (Intermediate Coronary Syndrome)Acute Coronary SyndromeAcute Myocardial Infarction
- Interventions
- Registration Number
- NCT02037412
- Lead Sponsor
- Yonsei University
- Brief Summary
The investigators hypothesized that ticagrelor may enhance endothelial healing after DES implantation by increasing adenosine concentrations by the inhibition of adenosine uptake into erythrocytes, compared to clopidogrel. Thus, the investigators will evaluate the extent of endothelialization (stent strut coverage) and neointimal hyperplasia (neointimal thickness) 3 months after DES implantation by optical coherence tomography (OCT)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 148
- Patients ā„ 20 years old
- Patients who are hospitalized and expected to undergo PCI for acute coronary syndrome, including acute myocardial infarction and unstable angina.
- Age > 80 years
- Cardiogenic shock or unstable patients
- Increased risk of bleeding, anemia, thrombocytopenia
- A need for oral anticoagulation therapy
- Pregnant women or women with potential childbearing
- Life expectancy < 1 year
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ticagrelor Arm Ticagrelor Ticagrelor Arm Clopidogrel Arm Clopidogrel Clopidogrel Arm
- Primary Outcome Measures
Name Time Method Stent re-endothelialization Three months after stent implantation Percentage of stent coverage measured by OCT
Neointimal hyperplasia Three months after stent implantation Neointimal thickness measured by OCT
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine
š°š·Seoul, Korea, Republic of